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Wales, Kensington, New South Wales, 2052, AustraliaABSTRACT The prion protein (PrP), widely recognized to misfold into the causative agent of the transmissible spongiform
encephalopathies, has previously been shown to bind to lipid membranes with binding influenced by both membrane composi-
tion and pH. Aside from the misfolding events associated with prion pathogenesis, PrP can undergo various posttranslational
modifications, including internal cleavage events. Alpha- and beta-cleavage of PrP produces two N-terminal fragments, N1
and N2, respectively, which interact specifically with negatively charged phospholipids at low pH. Our previous work probing
N1 and N2 interactions with supported bilayers raised the possibility that the peptides could insert deeply with minimal disruption.
In the current study we aimed to refine the binding parameters of these peptides with lipid bilayers. To this end, we used neutron
reflectometry to define the structural details of this interaction in combination with quartz crystal microbalance interrogation.
Neutron reflectometry confirmed that peptides equivalent to N1 and N2 insert into the interstitial space between the phospholipid
headgroups but do not penetrate into the acyl tail region. In accord with our previous studies, interaction was stronger for the N1
fragment than for the N2, with more peptide bound per lipid. Neutron reflectometry analysis also detected lengthening of the lipid
acyl tails, with a concurrent decrease in lipid area. This was most evident for the N1 peptide and suggests an induction of
increased lipid order in the absence of phase transition. These observations stand in clear contrast to the findings of analogous
studies of Ab and a-synuclein and thereby support the possibility of a functional role for such N-terminal fragment-membrane
interactions.INTRODUCTIONTransmissible spongiform encephalopathies (TSEs) or prion
diseases are fatal neurodegenerative diseases affecting hu-
mans and animals. Misfolded conformers of the prion
protein (PrPSc) are widely recognized as the causative agent
of TSEs with expression of wildtype or cellular prion
protein (PrPC) indispensable for disease transmission
and pathogenesis (1,2). During disease the predominantly
alpha-helical PrPC becomes misfolded into beta-sheet-rich
conformers that can template further misfolding of PrPC re-
sulting in propagation of pathogenic PrPSc.
The misfolding process has been replicated in vitro utiliz-
ing recombinant PrP (rPrP), and the development of a serial
protein misfolding amplification assay (PMCA) has made
production of misfolded rPrP highly efficient (3). However,
initial experiments with misfolded rPrP could only generateSubmitted July 7, 2014, and accepted for publication September 19, 2014.
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0006-3495/14/11/2313/12 $2.00a transmissible prion species if the PMCA reaction was
‘‘seeded’’ with infectious PrPSc taken from a disease source
(4). Such observations raised questions over the potential
role for cellular cofactors in PrPSc propagation. Various
anionic species have been suggested as cofactors in the pro-
duction of infectious prions; these have included nucleic
acids, glycosaminoglycans, and lipids (reviewed in (5,6)).
In the first study to report use of the PMCA to produce genu-
inely infectious (transmissible in animal bioassay) rPrP spe-
cies in the absence of an infectious disease-derived seed, a
combination of 1-palmitoyl-2-oleoyl-sn-glycero-3-[phos-
pho-rac-(1-glycerol)] (POPG) and nucleic acid cofactors
were required (7). In addition to the inclusion of pure phos-
pholipid species in misfolding reactions, synthetic mem-
branes of mixed lipid composition have also been
employed to mimic rPrP binding to cellular structures.
These studies have demonstrated the affinity of rPrP for
lipids, with binding invariably influenced by lipid composi-
tion, metal ion binding, and pH (8–10) and often resulting in
structural changes to rPrP that might predispose it to or
initiate misfolding (9–12).
Phospholipid-PrP binding interactions may have a
wider significance beyond protein misfolding. Although a
‘‘normal’’ PrPC function is still undetermined, suggestionshttp://dx.doi.org/10.1016/j.bpj.2014.09.027
2314 Le Brun et al.have included trafficking and signal transduction (reviewed
in (13)), functions intimately linked with membranes.
Mature PrPC is a glycosylphosphatidylinositol (GPI)-
anchored membrane protein directed to cholesterol-rich
membrane domains on the outer leaflet of the cell plasma-
membrane (14). These membrane domains are often associ-
ated with cellular signaling reactions and the control of
signal protein activation; such a localization may support a
role for PrPC in these functions. Part of the reason that eluci-
dating one individual function of PrPC has been challenging
is likely to be the influence of its posttranslational modifica-
tions. Protein cleavage is a cellular mechanism of functional
activation and deactivation. PrPC is known to undergo well-
characterized alpha- and beta-cleavage events as well as
secretory cleavage from the cell surface (14–17). Alpha-
cleavage occurs either side of residue 111 (15) producing
N1 and C1 fragments and the b-cleavage site is located
around residue 90 (18) producing N2 and C2 fragments.
The N1 and N2 fragments contain a far N-terminal polybasic
region and an octameric repeat, metal ion binding domain.
The fragments differ at their C terminus by one further poly-
basic region containing an additional metal ion binding site
that is only present in theN1 fragment. PrPC, therefore, exists
as a minimum of six different species before other posttrans-
lational modifications (such as complex glycosylation) are
considered, with the potential for differing functions of
different fragments depending on cellular environment. As
stated, posttranslational cleavage may be used for protein
activation or deactivation and, therefore, the fragments pro-
duced by these cleavages could be functional and may alter
the functional capacity of full-length PrP. Both the N1 and
N2 cleavage fragments have been demonstrated to have
neuroprotective functions (19,20), but the cleavage events
that produce them are thought to occur at different cellular
locations, with N1 produced in the Golgi (21) and N2 at
the cell surface (16), indicating their production may be
stimulated by different signals.
Our previous studies using synthetic N1 and N2 have
shown that the peptides have a propensity to interact with
anionic lipid membranes independent of the PrP globular
C terminus region (22). These studies suggested that the
liberated peptides could interact with the acyl chain core
of the bilayer membrane without substantially disrupting
the homogeneity of the lipid system and thus our previous
work raised the possibility that the peptides may insert
benignly through the bilayer. Our recent work aimed to
expand these findings by directly probing the peptide-lipid
interactions using neutron reflectometry (NR). NR directs
a beam of neutrons into a sample, measuring the intensity
of reflected neutrons as a function of momentum transfer.
The pattern of reflection in the context of membranes pro-
vides information on the thickness and composition of the
surface and from these the fluidity can be inferred by
deriving the area per lipid molecule. This technique was em-
ployed specifically for its capacity to accurately probe theBiophysical Journal 107(10) 2313–2324depth that a peptide penetrates into the bilayer, which can
be measured using isotopic labeling. Furthermore, NR is
nondestructive and nonperturbing, therefore giving a more
valid insight into the interactions within the sample. Our
findings show that both N1 and N2 interact with anionic
membranes at pH 5 as originally proposed without pore-
forming or lytic capacity but neither peptide penetrates
deeply into the membrane.MATERIALS AND METHODS
Vesicle and peptide preparation
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPG), 1-palmitoyl-2-oleoyl-
sn-glycero-3-[phospho-L-serine] (POPS), 1,2-dimyristoyl-sn-glycero-3-phos-
phocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]
(DMPG), 1-palmitoyl(d31)-2-oleoyl-sn-glycero-3-phosphocholine (d31-POPC),
1-palmitoyl(d31)-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (d31-POPG),
and 1-palmitoyl(d31)-2-oleoyl-sn-glycero-3-[phospho-L-serine] (d31-POPS)
were purchased from Avanti Polar Lipids (Alabaster, AL) and used without
further purification. Lipids were dissolved in chloroform/methanol (4:1 by
volume) in glass vials to give POPC only, POPC/POPG (2:1 molar ratio),
POPC/POPS (2:1 molar ratio), and DMPC/DMPG (2:1 molar ratio) lipid
mixtures. The same lipid ratios were used for preparing vesicles with
lipids containing the d31-palmitoyl chain. The solvent was evaporated
first by blowing nitrogen over the lipid solutions and then by storing under
vacuum overnight to remove any residual solvent. The dried lipid thin films
were hydrated with a buffered solution of 10 mM MOPS, 150 mM NaCl
pH 7.0 (in 100% D2O for NR experiments) with vortex mixing to a
concentration of 0.5 mg/mL. The hydrated lipid solutions were incubated
at 25C for PO-containing lipids and 30C for DM-containing lipids
for 1 h before small unilamellar vesicleswere prepared by sonicating the lipid
solution until clear.
Fluorescent large unilamellar vesicles (LUVs) for calcein release assays
were prepared as follows. Chloroform solutions (10 mg/mL) of 1-palmi-
toyl-2-oleoyl-sn-Glycero-3-phosphcholine (POPC) and 1-palmitoyl-2-
oleoyl-sn-Glycero-3-[phospho-rac-(1-glycerol)] (POPG) were combined
(2:1 w/w) in a round-bottom flask and the solvent removed by rotary
evaporation. The lipid film was hydrated in 10 mM Tris-HCl pH 7.4
(150 mM NaCl) containing 70 mM calcein (Sigma-Aldrich Pty Ltd,
Sydney, Australia) for 1 h at 40C with gentle agitation. The multilamellar
dispersion was freeze-thawed in liquid nitrogen five times, then extruded
through a 100 nm polycarbonate membrane 11 times. The resultant cal-
cein-loaded LUVs were passed through a column of Sephadex G25 resin
(Sigma) preequilibrated with 50 mM Na/K acetate pH 5.2 (130 mM
NaCl) to remove free calcein from the solution. Calcein-loaded LUVs
were diluted to a concentration of ca. 50 mM in acetate buffer immediately
before use.
The mouse PrP amino acid sequence was used to generate peptide frag-
ments corresponding to N1 (23-111) and N2 (23-90) cleavage fragments.
The Peptide Technology Laboratory (Bio21 Institute, University of
Melbourne) used microwave synthesis to prepare the peptides as previously
described (23). Verification of the peptide sequence and purity was per-
formed by HPLC and mass spectrometry. Freeze-dried peptides were dis-
solved in buffer (17 mM sodium acetate, 150 mM NaCl pH 5.0) to a
concentration of 10 mM immediately before use.Neutron reflectometry experiments and data
analysis
Polished n-type circular silicon wafers 100 mm in diam. and 10 mm thick
(El-Cat Inc., Ridgefield Park, NJ) were cleaned for 1 h at 85C in a strongly
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move surface impurities. After cleaning in the corrosive acid solution, the
silicon wafers were rinsed in Milli-Q water and dried before being UV-
ozone cleaned for 20 min. A final rinse with Milli-Q water and propan-
2-ol was carried out before drying under a stream of nitrogen. The silicon
wafers were assembled in aluminum cells with a silicon backing plate,
which had a 50 mm deep solvent reservoir and inlet and outlet tubes to allow
for solvent/sample exchange.
Neutron reflectivity data were measured using the Platypus time-of-
flight neutron reflectometer and a cold neutron spectrum (2.8 A˚ % l %
18.0 A˚) at the OPAL 20 MW research reactor (Sydney, Australia)
(24,25). Neutron pulses of 20 Hz were generated using a disc chopper sys-
tem (EADS Astrium GmbH, Munich, Germany) in the low resolution
mode (Dl/l ¼ 8%), and recorded on a two-dimensional 3He neutron de-
tector (Denex GmbH, Lu¨neburg, Germany). Reflected beam spectra were
collected for each of the surfaces at 0.45 for 15 min (0.72 mm slits), 1.6
for 45 min (2.56 mm slits), and 4.5 for 2 h (7.2 mm slits), respectively.
Direct beam measurements were collected under the same collimation
conditions for 1 h each. The data were reduced using the Slim reduc-
tion package, which stitches the three data sets together at the appro-
priate overlap region, re-bins the data at instrument resolution and
corrects for background and detector efficiency (26). The final scaled re-
flectivity, R, is presented as a function of momentum transfer, Q, defined
as follows:
Q ¼ 4p sinq
l
where q is the angle of incidence and l is the neutron wavelength. The re-
flectivity data was multiplied by Q4 to remove the Fresnel reflectivity andthus final reflectivity data presented as RQ4 versus Q.
Structural parameters for the native oxide layer on the silicon blocks,
lipid bilayer, and peptide layers were refined using the MOTOFIT reflectiv-
ity analysis software (27). In the fitting routines, the genetic algorithm was
selected to minimize c2 values by varying the thickness (t), roughness (s),
and neutron scattering length density (nSLD) of each layer. Model fitting of
the resulting reflectivity profiles yields information on the real space
neutron scattering length density profile normal to the surface, from which
the structure of a lipid bilayer may be deduced. The nSLD, r, can be consid-
ered as a neutron refractive index and is a function of the chemical compo-
sition of the material according to the following:
r ¼ NA
X
i
pi
Ai
bi
where NA is Avogadro’s number, pi is the mass density, Ai is the atomic
mass, and bi is the nuclear scattering length of component i. The errorsgenerated in the analysis software are51 standard deviation of the param-
eter value from which the percentage error was calculated. The advantage
of using neutrons, particularly for soft matter and biological systems, is the
difference in scattering length between hydrogen (bH ¼ -3.74 105 A˚)
and its isotope deuterium (bD ¼ þ6.67 105 A˚). By selective deuteration
of molecules (in this case the palmitoyl tails) different segments of the lipid
bilayer can be probed by choosing a suitable solvent contrast. We used
either a pure D2O solvent contrast (r ¼ 6.35 106 A˚-2) to highlight the
protonated peptide or pure H2O (r ¼ -0.56 106 A˚-2) to highlight the
partially deuterated lipid chains. When changing between different sub-
phase contrasts, the physical structure of the system is assumed not to
change. This means that the thickness and roughness parameters in the
models are constrained to be the same between each subphase while
only letting the scattering length density vary. This form of simultaneous
fitting provides for a unique solution to the model. The nSLD on each
component in a layer contributes to the final nSLD of the layer, rlayer,
such that
rlayer ¼

rlipid4lipid
þ ðrsolvent4solventÞ þ

rpeptide4peptide
where 4 is the volume fraction of each component. Once the volume
fraction has been determined the surface excess, G, of each component
(in mol m2) can be calculated from the following:
G ¼ 4t
VNA
where V is the molecular volume. From the surface of excess the lipid to
peptide ratio can be deduced.For consideration of changes in lipid order, the area per lipid molecule,
Alipid, is determined from the following:
Alipid ¼ V
4t
where V is the molecular volume of the lipid (1230 A˚3 for POPC/POPG
bilayers and 1226 A˚3 for POPC/POPS bilayers (28–30), 4 is the volumefraction, and t is half the total bilayer thickness. The values used to calcu-
late parameters can be found in Table S1 in the Supporting Material.Quartz crystal microbalance (QCM) experiments
and analysis
The Q-senseE4 instrument (Q-Sense, Gothenburg, Sweden) fitted with a
peristaltic pump (Ismatec SA, Glattbrugg, Switzerland) used a flow rate
of 100 mL min1, a constant temperature of 22C, and silicon dioxide-
coated sensor crystals (QSX-303, Q-sense). The sensor crystals were
cleaned by UV-ozone for 20 min, rinsing with 2% (v/v) Hellmanex fol-
lowed by copious rinsing with > 18 MU water and drying under nitrogen.
The sensors underwent a final clean using UV-ozone for 20 min immedi-
ately before use. The piezoelectric quartz crystal was excited at its
fundamental frequency (5 MHz) and the change in frequency (Df) was
observed for the third, fifth, seventh, ninth, eleventh, and thirteenth over-
tones. Data was collected using QSoft401 software and processed into fre-
quency and dissipation versus time data using Q-Tools 301 v2.1. A decrease
in frequency corresponds to an increased mass on the surface of the sensor.
For rigid films with little water content that have minimal changes in dissi-
pation (< 1), the Sauerbrey equation can be used to relate mass (Dm) and
frequency (Df) as follows:
Dm ¼ Df rqvq
2
ﬃﬃﬃ
F
p
n
where rq is the density of quartz (2648 kg m
3), vq is the speed of sound
through quartz (3340 m s1), F is the fundamental frequency (5 MHz),
and n is the overtone number. For each overtone the change in dissipation
(DD) was also measured. The dissipation is the proportion of energy dissi-
pated during one cycle of the frequency oscillation and provides informa-
tion on the viscoelastic properties of the materials deposited on the
sensor surface. For films that are nonrigid and have a dissipation that is
large (> 1), the Sauerbrey equation is no longer valid.
Vesicles prepared in buffer (50 mM sodium acetate/acetic acid pH 5.2,
130 mM NaCl) were deposited onto the silicon dioxide surface. Once the
vesicles had ruptured and the bilayer formed, the excess lipid was removed
with a buffer wash. Peptide at 10 mM prepared in the same buffer was added
and incubated on the bilayer for 60 min after which the excess peptide was
removed with a buffer wash.Calcein Release Measurements
For each condition, 95 mL of calcein-loaded LUVs was added to a black
96-narrow-well plate and the initial fluorescence (f0) monitored using a
POLARstar OPTIMA microplate reader (BMG LABTECH, Ortenberg,
Germany) using 480 5 10 nm excitation and 520 5 20 nm emission fil-
ters. Following addition of 5 mL peptide (100 mM N1, N2, or melittinBiophysical Journal 107(10) 2313–2324
2316 Le Brun et al.dissolved in MQ grade water), the solution briefly mixed by pipetting up
and down the fluorescence signal was further monitored as a function of
time. Finally, 5 mL Triton X-100 (10% v/v) was added to determine the
maximum fluorescence response (f1). The normalized fluorescence (f’)
was obtained from the raw fluorescence signal (f) using the following
expression:
f 0ðtÞ ¼ ½f ðtÞ  f0=½f1  f0:
RESULTS
NR is an established technique for studying the structure
of solid-supported phospholipid bilayers along the axis
perpendicular to the plane of the bilayer (the z-axis)
(31,32). The bilayers were generated using the vesicle depo-
sition technique (33) onto silicon oxide surfaces typically
15 5 1 A˚ thick and with an interfacial roughness of 3 A˚.
In these experiments we used mono-unsaturated diacyl
phospholipids where the palmitoyl chain was deuterated
so that there was contrast against the hydrogenous peptides.
For modeling the bilayer data, the bilayers were separated
into three discrete layers: headgroup one (closest to the
silicon oxide surface), acyl tails, and headgroup two (closest
to the bulk solvent). A 3 to 7 A˚ solvent layer between the
silicon oxide surface and headgroup one was included in
the model for each bilayer as previously described
(34,35). The experiments were conducted at room tempera-
ture, which is above the phase transition temperature of
POPC, POPG, and POPS (Tm of -2
C, -2C, and 14C,
respectively) and thus the bilayers were in the fluid (La)
phase. The thickness of the bilayers ranged from 38 5
3 A˚ to 56 5 3 A˚ (Table 1 and Tables S2 and S3) and theTABLE 1 Thickness and derived properties of the lipid bilayers wi
neutron reflectometry data
Layer
Thickness
(no peptide) / A˚ 4lipid (no peptide)
Thickness (peptide
bound) / A˚
d31-POPC/d31-POPG (2:1) bilayer þ N1 peptide
Headgroup 1 155 1 0.945 0.02 185 1
Tails 205 1 1.005 0.02 235 1
Headgroup 2 105 1 0.415 0.02 75 1
Peptide - - 215 2
d31-POPC/d31-POPS (2:1) bilayer þ N1 peptide
Headgroup 1 75 1 0.945 0.06 85 1
Tails 205 1 1.005 0.02 295 1
Headgroup 2 115 1 0.945 0.03 95 1
Peptide - - 215 1
d31-POPC/d31-POPG (2:1) bilayer þ N2 peptide
Headgroup 1 75 1 0.565 0.01 75 1
Tails 275 1 1.005 0.02 315 1
Headgroup 2 115 1 0.865 0.03 125 1
Peptide - - 275 3
d31-POPC/d31-POPS (2:1) bilayer þ N2 peptide
Headgroup 1 135 1 0.895 0.02 125 1
Tails 265 1 0.985 0.01 275 1
Headgroup 2 185 1 0.245 0.02 165 1
Peptide - - 205 2
Biophysical Journal 107(10) 2313–2324area per lipid molecule ranged from 35 to 47 A˚2 in the tail
region. These observations are consistent with molecular
dynamics simulation data of POPC bilayers in the fluid
phase (28).
For all NR experiments a peptide concentration of
10 mM in a pH 5.0 buffer was employed, which has been
previously shown to be effective for binding to anionic bi-
layers (18). The approach used was bilayer formation and
characterization after which peptide was incubated on the
surface and then the excess removed with a pH 5.0
buffer wash in either D2O or H2O. When both the N1
and N2 peptides were added to zwitterionic d31-POPC bi-
layers, no change in reflectivity was observed (Fig. S1)
and no presence of peptide is observed in the correspond-
ing real space nSLD profile. This corresponds with previ-
ous data that the N1 and N2 peptides do not bind to
zwitterionic bilayers (22).
When the N1 peptide was added to the negatively
charged d31-POPC/d31-POPG (2:1 molar ratio) bilayer, a
reduction in the intensity of the fringe at Q ¼ 0.101 A˚-1
was observed along with a slight shift in fringe position
to a lower value of Q by 0.01 A˚-1 (compare black and
red reflectivity profiles in Fig. 1 A). These changes indicate
that the N1 peptide bound to the d31-POPC/d31-POPG
bilayer without dramatic structural changes to the bilayer.
A similar effect was observed when the N1 peptide was
added to a d31-POPC/d31-POPS (2:1 molar ratio) bilayer;
however, the reduction in the intensity was less than
for d31-POPG-containing bilayers suggesting that less
peptide was bound to the bilayer (Fig. 1 B). The modeling
of the data to produce the real-space nSLD profiles
provided more details on the membrane-bound peptideth and without N1 and N2 peptide bound from the fitting of the
4lipid (peptide
bound) 4peptide Glipid / mmol m
2 Gpeptide / mmol m
2
0.755 0.01 - 7.465 0.12 -
1.005 0.01 - 4.115 0.01 -
0.105 0.01 0.475 0.01 0.395 0.01 0.075 0.01
- 0.155 0.01 - 0.085 0.01
0.995 0.03 - 4.585 0.16 -
0.975 0.01 - 4.855 0.05 -
0.085 0.01 0.475 0.01 0.425 0.01 0.075 0.01
- 0.255 0.01 - 0.085 0.01
0.565 0.02 - 2.305 0.09 -
1.005 0.02 - 5.385 0.12 -
0.145 0.05 0.335 0.01 0.905 0.03 0.085 0.01
- 0.205 0.03 - 0.125 0.01
0.785 0.02 - 5.445 0.11 -
0.895 0.01 - 4.175 0.05 -
0.205 0.01 0.535 0.01 1.905 0.03 0.185 0.01
0 0.285 0.01 - 0.125 0.01
FIGURE 1 Neutron reflectometry of the N1
peptide binding to solid-supported phospholipid
bilayers on silicon: (a) d31-POPC/d31-POPG (2:1)
bilayer, (b) d31-POPC/d31-POPS (2:1) bilayer, the
symbols with error bars are the data and the solid
lines the fit. The corresponding real-space nSLD
profile from the fits is also shown: (c) d31-POPC/
d31-POPG (2:1) bilayer, (d) d31-POPC/d31-POPS
(2:1) bilayer. The dashed vertical lines delineate
the different layers in the peptide bound state. In
all panels black (B) is bilayer before N1 peptide
addition in D2O, red (,) is bilayer with N1 pep-
tide bound in D2O, and green (6) is bilayer with
peptide bound in H2O. To see this figure in color,
go online.
Neutron Reflectometry of PrP Peptides 2317(Fig. 1 C and D). There was no change in the nSLD of the
acyl tails region before peptide addition or when peptide
was bound to both the d31-POPG- and d31-POPS-contain-
ing bilayers in the D2O contrast. This shows that the N1
peptide does not penetrate into the bilayer acyl tail layer.
Additionally, changing the isotopic contrast to H2O in the
presence of the N1 peptide also showed no isotopic-depen-
dent change in the nSLD of the bilayer tails region, which
further confirms the acyl tails layer is devoid of peptide
and that there is no detectable pore-formation by the pep-
tide. The calculated volume fractions of the lipid tails
before and after peptide addition showed that there was
no loss of lipid from the surface (Table 1), also suggesting
no detectable peptide action through the membrane lysis
process known as the ‘‘carpet mechanism’’ (36). The
most profound effect that the N1 peptide had on both
bilayers was in the outer headgroups of the phospholipids.
The N1 peptide was present in this region along with
solvent. Using the volume fractions of lipid and peptide,
the surface excess and lipid-to-peptide ratio for the outer
headgroup was calculated. From the lipid-to-peptide ratios
in Fig. 2 it can be seen that a higher amount of peptide is
bound to the d31-POPG-containing bilayer than the d31-
POPS-containing bilayer, indicating a stronger interactionbetween d31-POPG and the N1 peptide than for d31-
POPS. Both bilayers have a 21 A˚ layer of peptide above
membrane. The peptide layer is not dense; having a
peptide volume fraction of 0.15 and therefore a high sol-
vent content (Table 1). A further observation was that the
thickness of the acyl tail zone was increased on peptide
binding, indicating a potential increase in lipid ordering
(Table 1). This was also evident as a contraction of the
area per lipid molecule of the membrane following peptide
addition (Table 2), but no phase transition of the lipids was
seen.
NR showed the N2 peptide displayed similar behavior to
the N1 peptide when binding to negatively charged phos-
pholipid bilayers. As with the N1 peptide, when N2 was
bound to solid-supported bilayers the intensity of the fringe
at Q ~ 0.1 A˚-1 decreased suggesting that the N2 peptide
bound to the bilayer (Fig. 3 A and B). For the H2O contrast
in the d31-POPC/d31-POPS bilayer with N2 bound (Fig.3
B) the background of the data points did not match the
fitted curve; however, the fit is still within a reasonable
c2 value of 1.24. When the background was constrained,
a poorer fit that was not biologically credible resulted.
The real-space nSLD profile showed no presence of pep-
tide in the acyl tail region for both d31-POPC/d31-POPGBiophysical Journal 107(10) 2313–2324
FIGURE 2 The lipid-to-peptide ratio of N1 and N2 peptides in the outer
headgroups in anionic phospholipid bilayers as determined from neutron
reflectometry data.
2318 Le Brun et al.bilayer and d31-POPC/d31-POPS bilayers (Fig. 3 C and D).
The d31-POPS-containing bilayer showed an isotopic
dependent change in the tail layer when changing between
the D2O and H2O contrasts, highlighting the presence of
solvent in the tail region (Fig. 3 D). The volume fraction
of the solvent in the tail region of the d31-POPC/d31-
POPS bilayer was 0.11 with the lipid volume fraction
reducing down to 0.89 indicting some loss of lipid material
from the surface. This marginal loss of lipid material over
the period that the peptide was bound to the bilayer (~ 7 h)
makes it unlikely that the N2 peptide has any lytic or pore-
forming mechanism. The predominant binding of the N2
peptide was at the outer headgroups forming a peptide
layer above the bilayer in both negatively charged mem-
branes. The lipid-to-peptide ratio of the N2 peptide in the
outer headgroup region for each bilayer was calculated.
Fig. 2 shows that there was essentially no difference in
the lipid-to-peptide ratio between d31-POPG- or d31-
POPS-containing bilayers. However, the lipid-to-peptide
ratio of N1 was higher than N2 in both cases indicating
less N2 bound to the bilayer than N1.
The NR data clearly indicates that the N1 and N2 pep-
tides do not insert into the hydrophobic tail region of a
phospholipid bilayer. To further confirm the absence of
tail insertion by the N1 and N2 peptides (and to ensure
the current results were not because of batch variation in
peptides), we conducted QCM-D experiments comparingTABLE 2 The change in area per lipid molecule upon binding
N1 and N2 peptides
Bilayer Peptide
Alipid before peptide
addition / A˚2
Alipid after peptide
addition / A˚2
POPC / POPG (2:1) N1 555 4 51 5 4
POPC / POPS (2:1) N1 655 7 54 5 4
POPC / POPG (2:1) N2 555 5 49 5 4
POPC / POPS (2:1) N2 445 3 50 5 3
Biophysical Journal 107(10) 2313–2324the N1 and N2 fragments with melittin from bee venom, a
peptide known to insert into the hydrophobic tails of anionic
phospholipid bilayers (37). Fig. S2 shows that when melittin
is added to a bilayer of POPC/POPG (2:1) or POPC/POPS
(2:1) the dissipation increases, the overtones no longer over-
lap, and the Sauerbrey equation is no longer valid as is
consistent with recent publications (38). This is indicative
of the vibration of the bilayer no longer being in concert
with the vibrations of the oscillating quartz crystal because
of the increased hydration of the bilayer. Although the
mass of the bound melittin cannot be determined through
the use of the Sauerbrey equation, the frequency of each
overtone remains more negative than the frequency of the
bilayer. This shows that there is an overall mass gain sug-
gesting the increased hydration of the bilayer rather than
loss of lipid material from the surface (which would result
in a less negative frequency than the initial bilayer). As
can be seen, the QCM-D trace for the addition of melittin
was very different from that of either the N1 or N2 peptides
binding to anionic bilayers (Fig. 4). The QCM-D traces for
the N1 and N2 peptides (N2 trace presented in Fig. 4 and
tabulated results shown in Table S4) show an overall mass
gain on the bilayer indicating no lytic action by the peptides
and all the overtones overlap with a low dissipation indi-
cating that the bilayer was intact and had not changed its
hydration state. Control QCM-D experiments were also
conducted with DM lipids with no differences found from
the PO lipids (Table S4). By plotting Df versus DD, time
is excluded as a parameter and the plot shows how the lipid
bilayer structure changes per unit of peptide mass added.
This provides a ‘‘finger print’’ of the mechanistic action of
peptides with lipid bilayers (39). Fig. 5 shows the Df-DD
plots for N1 and N2 binding to both the POPG and
POPS-containing bilayers. The origin of the each graph in
Fig. 5 is the point of peptide addition (the point marked
PA in Fig. 4 A). In all cases there is a linear increase of
DD with increasing mass (i.e., a more negative Df) as the
peptide is binding to the bilayer until the lipid bilayers are
saturated with peptide and there is no further change in
Df or DD resulting in the large cluster of data points on
the right-hand of each graph. The shape of data in Fig. 5
is indicative of peptides that have minimal structural impact
on lipid bilayers and is similar to the nonlytic peptides api-
daecin (40) and oncocin (41). Finally, to further ensure min-
imal membrane perturbation and no lytic activity of the
peptides calcein release from LUVs in response to the N1
and N2 peptides was compared with the action of melittin
in POPC and POPC/POPG (2:1) vesicles (Fig. 6). No
change from baseline fluorescence was seen for the POPC
LUVs and minimal fluctuation was measured for the
POPC/POPG LUVs when exposed to the N1 and N2 pep-
tides compared with melittin, which demonstrated rapid
and almost complete release. These results further exclude
pore-formation by N1 or N2 and confirm our previous
findings.
FIGURE 3 Neutron reflectometry of the N2 pep-
tide binding to solid-supported phospholipid bila-
yers on silicon: (a) d31-POPC/d31-POPG (2:1)
bilayer, (b) d31-POPC/d31-POPS (2:1) bilayer, the
symbols with error bars are the data and the solid
lines the fit. The corresponding real-space nSLD
profile from the fits is also shown: (c) d31-POPC/
d31-POPG (2:1) bilayer, (d) d31-POPC/d31-POPS
(2:1) bilayer. The dashed vertical lines delineate
the different layers in the peptide bound state. In
all panels black (B) is bilayer before peptide addi-
tion in D2O, red (,) is bilayer with N2 peptide
bound in D2O, and green (6) is bilayer with N2
peptide bound in H2O. To see this figure in color,
go online.
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The NR data presented in the current study confirm the bind-
ing capabilities of the N1 and N2 endogenous cleavage frag-
ments to phospholipid model membranes and further defines
the specific engagement and changes to the lipid environ-
ment upon peptide binding. Our previous work showed in-
teractions of the N1 and N2 peptides with anionic lipids
that were consistent with either benign uniform insertion
of the peptide across the bilayer or no insertion with peptide
bound to the surface of the bilayer causing lipid ordering
(22). Previous studies using 2H-solid-state NMR with only
the palmitoyl chain of the POPC lipid labeled with deute-
rium in a 2:1 mixture of POPC:POPS were only able to
report on the ordering effect on 33% of the tails in the lipid
mixture. The 2H chemical shift anisotropy increased from
23.2 kHz for lipid only to 25.6 and 24.4 kHz in the presence
of N1 and N2, respectively, indicating an ordering of the
palmitoyl tails in POPC. This modest increase in ordering
could reflect peptides inserting into the lipid tails; however,
the increases did not account for a substantial perturbation
in the freedom of movement of the palmitoyl tails associated
with bilayer disruption and could suggest that the N1 and N2
peptides do not interact with the bulk lipid bilayer (22). In
the study all parts of the lipid bilayer and the peptide wereobserved providing a complete picture and strong support
that the latter situation is true, finding that binding was pri-
marily in the outer headgroup region with no penetration
into the acyl tails, and also confirmed that the binding affin-
ity is greater for N1 than N2 on both the POPS/POPC and
POPG/POPC bilayers, most likely because of the additional
polybasic region at the C terminus of the N1 peptide (15).
Therefore, these data continue to support a nonperturbing
PrP N1/N2-lipid interaction and are not consistent with
the peptide causing bilayer damage by other lipid disrup-
tions such as the carpet mechanism (36).
Our findings contrast with NR studies of the neurotoxic
peptide amyloid-beta (Ab) found in Alzheimer’s disease
that, in combination with atomic force microscopy, shows
globular aggregates of freshly prepared Ab1-40, Ab1-42,
or both are adsorbed to the membrane and disruptively pene-
trate into the core increasing hydration (42). Further, once
the Ab has initially inserted into the hydrophobic core of
negatively charged lipids, causing disordering of the lipids,
an induction of folding and template assembly of Ab fibrils
occurs (43). As with the N1 and N2 peptides, Ab forms a
peptide layer on the surface of the lipid bilayer. However,
with Ab, a thicker (~ 40 A˚), more crystalline layer is formed
than observed with N1 and N2 (43). The binding parameters
of the N1 and N2 peptides also differ from those ofBiophysical Journal 107(10) 2313–2324
FIGURE 4 The QCM-D of 10 mM N2 peptide
binding to a phospholipid bilayer of POPC/POPS
(2:1). The upper panel shows the Df trace on the
left (black trace) and the DD trace is shown on
the right (red trace). The 3rd, 5th, 7th, 9th, 11th,
and 13th overtones are shown but are indistin-
guishable as all overtones overlap. The lower panel
shows the corresponding Sauerbrey mass at
each step of the measurement with final masses
deposited indicated. VD—vesicle deposition,
VR—vesicle rupture, BF—bilayer formation,
BW—buffer wash, PA—peptide addition. To see
this figure in color, go online.
2320 Le Brun et al.a-synuclein, which forms intracellular aggregates called
Lewy bodies in Parkinson’s disease. Similar to N1 and
N2, a-synuclein mainly embeds in the outer headgroups
of mixed lipid bilayers containing anionic lipids, with a
greater binding affinity seen at lower pH (44), but its mem-
brane interaction causes thinning of the bilayer rather than
the thickening effect seen for the PrP fragments. Also, bind-
ing to lipid membranes is known to induce a helical second-Biophysical Journal 107(10) 2313–2324ary structure of a-synuclein (45), although we previously
observed the formation of increased beta-sheet secondary
structure on binding of N2 to PC/PS (22). The structural
change of a-synuclein and its lipid interactions is thought
to be involved in disease pathogenesis (46). A similar situ-
ation is unlikely to be true for N1 and N2 given these frag-
ments do not contain the amyloidogenic region of PrP and
the data presented indicate that the membrane binding
FIGURE 5 Df-DD plots from the QCM-D data
of (a) 10 mM N1 or (b) N2 binding to POPC/
POPS (2:1) bilayers, or binding to (c and d)
POPC/POPG (2:1) bilayers. The data shown is
from the 3rd (black), 5th (red), 7th (green), 9th
(blue), 11th (magenta), and 13th (cyan) overtones.
To see this figure in color, go online.
Neutron Reflectometry of PrP Peptides 2321events of these N-terminal fragments of PrP appear mini-
mally perturbing and would not be expected to be directly
toxic to cells. Indeed viability studies in cells have shown
that these peptides do not cause lysis and are not toxic
but instead demonstrate cytoprotective properties (19,20).
Considering these properties, and that the N1/N2 binding
events show no evidence of being acutely damaging to
membranes, these interactions may be relevant to the
cellular functions of these fragments and/or full-length PrP.
Analysis of the NR data of N1 and N2 peptide binding to
POPG and N1 binding to POPS containing membranes
showed that there was a thickening of the lipid bilayer,
reducing the area per lipid. Such changes are indicative of
an ordering of the lipids in the absence of a phase transition.
Changes in lipid order are required for the formation of scaf-
folds for protein binding and the assembly of multimeric
protein complexes, such as those associated with Annexin
A6 (47), which through structuring membrane domains
and linking with actin were found to be involved in mem-
brane repair. Interestingly, PrPC has been reported to bind
to a number of proteins, with the N-terminal region (resi-
dues 23–32) also containing a tubulin binding site (48), indi-
cating that full length PrPC and the N1 and N2 fragments
could link a protein scaffold to lipid membrane domains
and result in membrane ordering events under specific cir-
cumstances. The membrane ordering changes were not
observed for the N2 peptide with the POPS-containingmembrane. This may have a technical basis, most likely
because of the small loss of lipid from the bilayer over the
time of the experiment. We do not believe that this neces-
sarily represents a biologically relevant event as the NR ex-
periments were run over a period of hours but we have
previously shown that the half-life of this peptide in cell sys-
tems is very short, approximately minutes (20), and there-
fore it is unlikely to persist for sufficiently long times to
cause such an effect in vivo.
The N-terminal domain of PrPC has been shown to con-
trol PrPC membrane relocalization from lipid rafts and
subsequent clathrin mediated internalization (49). The for-
mation of protein scaffolds supporting tubule formation
for budding of trafficking vesicles requires organization of
the lipid membrane domain to which the protein scaffold
attaches. The ability to engage a lipid scaffold may be
highly important for the trafficking of full-length PrPC and
potentially the N-terminal cleavage fragments. However,
the absolute dependence on low pH for the observed mem-
brane interactions suggests that any physiological role of N1
or N2 interaction with anionic lipids is likely to occur inside
the cell in organelles of increased acidity. N-terminal inter-
actions may also direct trafficking once inside the cell. A pH
of 5 is representative of the pH within late endosomes, from
which PrPC might undergo retrograde transportation to the
Golgi (50), be transferred to recycling endosomes or multi-
vesicular bodies, or it may be targeted to lysosomes forBiophysical Journal 107(10) 2313–2324
FIGURE 6 Calcein release from (a) POPC or (b) POPC/POPG (2:1)
LUVs when exposed to N1 (blue), N2 (green), or melittin (red) peptides.
Triton X-100 was added to demonstrate maximum release. To see this
figure in color, go online.
2322 Le Brun et al.destruction. N-terminal engagement with intracellular
membranes may therefore be as part of an endosomal sort-
ing signal and direct the final destination of PrPC and/or its
N-terminal cleavage fragments. A role in membrane interac-
tion that directs intracellular trafficking might also account
for intricate changes that alter exosomal membrane struc-
ture during prion disease (51). Exosomes are formed
through membrane fission from multivesicular bodies (52)
to which PrPC may become directed by endosomal traf-
ficking. Notably, N-terminal processing of PrPC is altered
in exosomes from prion-infected cells (53).
Ordering of lipids is also seen in the formation of mem-
brane signaling complexes. An alternative hypothesis to
N1 and N2 being involved in dictating intracellular traf-
ficking is that their endocytosis is required to permit the for-
mation of membrane signaling complexes. Endosomes are
known to have a role in cellular signaling, controlling the
‘‘off’’ and ‘‘on’’ of some pathways (54). The pathways acti-
vated or deactivated are influenced by their type, maturity
and cellular location (55). We have found that the protectiveBiophysical Journal 107(10) 2313–2324signaling of N2 is transduced through MEK1 only after
correct engagement of its internalization pathways (C. L.
Haigh, unpublished observations). Therefore, endocytosis
of N1 and/or N2 may instigate a lipid-protein engagement
that facilitates intracellular signaling.
Although the observed membrane interactions of the
N-terminal peptides did not indicate that such contact could
be responsible for toxicity during disease, they may still be
relevant to pathogenesis in the context of PrP misfolding.
The involvement of POPG in the formation of genuinely in-
fectious misfolded rPrP (7,56) suggests that the ability of
PrP to bind these lipids as a full-length protein could be
important for the generation of prions. Misfolding during
prion disease is significantly more efficient if the N-terminal
regions of PrP are present (57), and it has been shown that
POPG binding to rPrP results in a structural change that ex-
poses a cryptic binding site for the N-terminal polybasic
region that may enhance further rPrP recruitment and tem-
plated misfolding (58). In cell cultures, high levels of PrP
a-cleavage confer resistance to prion infection (59), most
likely because the C1 fragment serves as a suboptimal sub-
strate for misfolding; however, b-cleavage is seen to be
increased during disease (18). In a cellular context, a greater
ratio of C2 to full length PrP could result in aberrant mem-
brane binding of C2, permitting conformational change and
thus enhanced production of misfolded PrP during disease.
b-cleavage leaves the core of misfolded PrP intact and C2
retains the second polybasic site that might substitute for
23-28. Studies considering rPrP fragments equivalent to
the C2 region of PrPC have shown that the ability to bind
lipids and misfold is maintained (60). Additionally, the
central domain has a significant role in lipid binding in
full-length PrPC and is influenced by disease-associated
mutations of the proline residues at 102 and 105 (mouse
sequence) to leucine residues (61). This supports that the
N1 peptide should have a greater capacity to bind lipids
than the N2 fragment that lacks this central domain,
although disruption of lipid membranes is only observed
for misfolded and aggregated rPrP, not for monomeric
rPrP (60), supporting that N1 or N2 are unlikely to be mem-
brane disruptive in vivo. When the N2 peptide was added to
cells in culture at high concentrations (10 mM), a very small
amount of dimer could be visualized by western blotting
but no higher molecular weight oligomers, which were
observed for a peptide with the prolines of the 23-28 poly-
basic region mutated to alanines (20). This indicates that
the propensity for the N-terminal fragments to oligomerise
and for any putative oligomers to cause membrane damage
is also low.
Much previous work looking at PrPC and lipid binding
has focused on full-length recombinant PrP, thus remaining
open to the criticism that, because rPrP is not GPI-anchored
or complex glycosylated, it may not be accurately represen-
tative. The peptides used in the current study are representa-
tive of genuine cleavage fragments that occur in the brain
Neutron Reflectometry of PrP Peptides 2323(18), separating the N-terminus from the structured, glyco-
sylated, and membrane-anchored C terminus, and the data
therefore present a stronger argument for how these
cleavage fragments interact with cell membranes. Both
N-terminal cleavage fragments have been shown to have
neuroprotective functions and therefore lipid binding
interactions could be crucial for these peptides to effect
protection. The binding parameters of full length PrPC,
especially in the context of membrane anchoring, remain
to be determined; however, the data presented herein sug-
gest that specific lipid binding interactions could potentially
be corrupted during prion disease, when the cleavage events
shift toward greater b-cleavage.CONCLUSION
The new data generated by NR support our previous findings
that endogenous PrP N-terminal cleavage fragments can
interact with negatively charged supported phospholipid bi-
layers at low physiological pH. We further show that this
interaction lies predominantly at the level of the phospho-
lipid headgroups with no clear penetration into the acyl
tail plane and without damage to the structural integrity of
the membrane but with induction of a domain ordering
effect. These observations stand in clear contrast to the find-
ings of analogous studies of Ab and a-synuclein and thereby
support the possibility of a functional role for such N-termi-
nal fragment-membrane interactions.SUPPORTING MATERIAL
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